14T172: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II (2515–2520)

Presenting Author(s)

• EB

  Erdem Bektaş, MD

  Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine
  Istanbul, Turkey

  Disclosure information not submitted.
• SI

  Shinji Izuka, MD

  University of Tokyo
  Bunkyo-ku, Tokyo, Japan

  Disclosure information not submitted.
• CJ

  Charles Jones, DM, MRCP (he/him/his)

  Hemay Pharmaceuticals
  Naples, FL, United States

  Disclosure information not submitted.
• CL

  Carmen Lasa Teja, MD

  Hospital Universitario Marqués de Valdecilla
  Anero, Spain

  Disclosure information not submitted.
• AL

  Antony Lin, MD

  Kaiser SCAL Los Angeles
  Fontana, CA, United States

  Disclosure information not submitted.
• OS

  Olga Sanchez Pernaute, MD, PhD

  Fundacion Jimenez Diaz Univ. Hospital
  Madrid, Spain

  Disclosure information not submitted.

Abstract oral session.

Non-CME

Presentations:

• 4:00 PM - 4:10 PM PT

  Machine Learning-Based Stratification of Mixed Connective Tissue Disease Using Immunophenotyping Data from Patients with Related Autoimmune Diseases
  

  Presenting Author: Shinji Izuka, MD – University of Tokyo
• 4:10 PM - 4:15 PM PT

  Q&A
  
• 4:15 PM - 4:25 PM PT

  The Effect of Starting Prednisone Dose on the Treatment of Polymyalgia Rheumatica
  

  Presenting Author: Antony Lin, MD – Kaiser SCAL Los Angeles
• 4:25 PM - 4:30 PM PT

  Q&A
  
• 4:30 PM - 4:40 PM PT

  The Relationship Between the NETosis Findings and Disease Activity in Behcet Disease
  

  Presenting Author: Erdem Bektaş, MD – Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine
• 4:40 PM - 4:45 PM PT

  Q&A
  
• 4:45 PM - 4:55 PM PT

  Could the Adenosine Pathway Identify Cases with a Progressive Fibrosing Phenotype Between Patients with Autoimmune Interstitial Lung Disease? An Initial Approach
  

  Presenting Author: Olga Sanchez Pernaute, MD, PhD – Fundacion Jimenez Diaz Univ. Hospital
• 4:55 PM - 5:00 PM PT

  Q&A
  
• 5:00 PM - 5:10 PM PT

  A Phase II Clinical Study to Investigate the Efficacy and Safety of Hemay005 Tablets in Patients with Active Behçet`sDisease
  

  Presenting Author: Charles Jones, DM, MRCP (he/him/his) – Hemay Pharmaceuticals
• 5:10 PM - 5:15 PM PT

  Q&A
  
• 5:15 PM - 5:25 PM PT

  Identification of Clinical Phenotypes in Sarcoidosis Using a Cluster Analysis
  

  Presenting Author: Carmen Lasa Teja, MD – Hospital Universitario Marqués de Valdecilla
• 5:25 PM - 5:30 PM PT

  Q&A